CPH-I, a predictive model based on serum CA125, and HE4 levels, and age of the patient (Karlsen et al., 2015 [11]), has been confirmed to have a similar ability to distinguish epithelial ovarian cancer from benign ovarian tumors as that of ROMA and RMI. Here, WFDC2 is linked to ovarian carcinoma.